Alterations in these SLiMs that mediate BRCA1–BRIP1 interaction have been associated with various cancer types, including breast cancer (BC), ovarian cancer, and pancreatic cancer [25,26,27,28,29]. Here, BRIP1 is linked to breast cancer.